Pharmaceuticals
CVS is considering a break up. Here’s why that could be risky
A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty Images ...
CVS is working with advisors on strategic review, sources say
CVS Health’s board has engaged advisors to conduct a strategic review of its business, according to people familiar with the ...
FDA approves Bristol Myers Squibb’s schizophrenia drug
Bristol Myers Squibb’s Cobenfy drug Courtesy: Bristol Myers Squibb The Food and Drug Administration on Thursday approved Bristol Myers Squibb‘s ...
Novo Nordisk CEO testifies at Senate over weight loss drug prices
Novo Nordisk‘s top executive faces a Senate grilling on Tuesday over the high prices of the company’s weight loss drug ...
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time ...
FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of ...
Pfizer’s cancer cachexia drug shows positive midstage trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
We’re taking a nearly 300% profit on a hot drug stock
Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, ...
FDA authorizes Novavax Covid vaccine targeting JN.1
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. Dado Ruvic | Reuters ...
